Suzuken Co., Ltd. (TYO:9987)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Distribution	2.40T	2.31T	2.30T	2.23T	2.14T
Pharmaceutical Distribution Growth	3.76%	0.64%	3.24%	3.85%	5.12%
Specialty Drug Contract Distribution Business	436.10B	295.49B	-	-	-
Specialty Drug Contract Distribution Business Growth	47.59%	-	-	-	-
Healthcare Product Development	51.64B	52.61B	51.30B	44.38B	43.94B
Healthcare Product Development Growth	-1.86%	2.57%	15.58%	1.01%	1.33%
Community Healthcare and Nursing Care Support Business	93.94B	94.41B	97.46B	87.74B	88.82B
Community Healthcare and Nursing Care Support Business Growth	-0.51%	-3.13%	11.08%	-1.21%	-1.41%
Healthcare Related Services	42.96B	42.19B	261.60B	228.69B	181.76B
Healthcare Related Services Growth	1.84%	-83.87%	14.39%	25.82%	27.46%
Intersegment sales and transactions	-539.00B	-398.72B	-323.05B	-272.91B	-226.08B
Total	2.49T	2.40T	2.39T	2.31T	2.23T
Total Growth	3.61%	0.56%	3.10%	3.67%	4.91%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	2.49T	2.40T	2.39T	2.31T	2.23T
Japan Growth	3.61%	0.56%	3.10%	3.67%	4.91%
Total	2.49T	2.40T	2.39T	2.31T	2.23T
Total Growth	3.61%	0.56%	3.10%	3.67%	4.91%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error